Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- A8381 BIBR-1048Summary: Thrombin inhibitor
- A8566 GSK744 (S/GSK1265744)Summary: HIV integrase inhibitor, oral active and long-acting
- A8621 Bestatin hydrochlorideTarget: AminopeptidasesSummary: Inhibitor of aminopeptidase N (APN)/CD13 and aminopeptidase B.
- A8650 SaxagliptinTarget: DPP-4Summary: Selective DPP4 inhibitor
- A9901 Caspase Inhibitor Set ISummary: Caspase Inhibitors
- B3232 Z-IETD-FMK12 CitationTarget: CaspasesSummary: Caspase-8 inhibitor
- B3233 Z-LEHD-FMK8 CitationTarget: CaspasesSummary: Irreversible Caspase-9 inhibitor.
- C5818 MMP-2 Inhibitor IISummary: irreversible inhibitor of MMP-2
- C5830 PD 145305Summary: selective inhibitor of calpains
- A1902 Z-VAD-FMK102 CitationTarget: CaspasesSummary: pan-caspase inhibitor